BNP PARIBAS FINANCIAL MARKETS

Holdings History for Eton Pharmaceuticals, Inc. - Common Stock (ETON)

Symbol: ETON on Nasdaq
Investment type: Equity / Common Stock

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Price	All Holders
31 Dec 2025	0%	0%	$4,691,815	277,458	$16.91	Q4 2025
30 Sep 2025	0%	0%	$4,993,337	229,790	$21.73	Q3 2025
30 Jun 2025	0%	0%	$1,249,668	87,696	$14.25	Q2 2025
31 Mar 2025	0%	0%	$510,335	39,317	$12.98	Q1 2025
31 Dec 2024	0%	0%	$4,662	350	$13.32	Q4 2024
30 Sep 2024	0%	0%	$2,100	350	$6.00	Q3 2024
30 Jun 2024	0%	0%	$1,152	350	$3.29	Q2 2024
31 Mar 2024	0%	0%	$1,312	350	$3.75	Q1 2024
31 Dec 2023	0%	0%	$1,533	350	$4.38	Q4 2023
30 Sep 2023	0%	0%	$1,460	350	$4.17	Q3 2023
30 Jun 2023	0%	0%	$1,222	350	$3.49	Q2 2023
31 Mar 2023	0%	0%	$1,348	350	$3.85	Q1 2023
31 Dec 2022	0%	0%	$987	350	$2.82	Q4 2022
30 Sep 2022	0%	0%	$735	350	$2.10	Q3 2022
30 Jun 2022	0%	0%	$917	350	$2.62	Q2 2022
31 Mar 2022	0%	0%	$1,526	350	$4.36	Q1 2022
31 Dec 2021	0%	0%	$3,037	708	$4.29	Q4 2021
30 Sep 2021	0%	0%	$3,856	765	$5.04	Q3 2021
30 Jun 2021	0%	0%	$10,059	1,633	$6.16	Q2 2021
31 Mar 2021	0%	0%	$15,804	2,159	$7.32	Q1 2021
31 Dec 2020	0%	0%	$23,959	2,947	$8.13	Q4 2020
30 Sep 2020	0%	0%	$24,869	3,148	$7.90	Q3 2020
30 Jun 2020	0%	0%	$3,008	552	$5.45	Q2 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.